HB 2105 Modifies provisions relating to opioids

     Handler: Onder

Current Bill Summary

- Prepared by Senate Research -


SCS/HCS/HB 2105 - This act modifies several provisions, including: (1) the "Show-Me Freedom from Opioid Addiction Decade"; (2) limitations on prescribing opioids; (3) disposal of unused controlled substances; (4) the "Offenders Under Treatment" program; (5) substance abuse treatment by assistant physicians; (6) patient satisfaction scores; and (7) the "Improved Access to Treatment for Opioid Addictions Act".

"SHOW-ME FREEDOM FROM OPIOID ADDICTION DECADE (Section 9.192)

This act designates 2018 to 2028 as the "Show-Me Freedom from Opioid Addiction Decade".

This provision is identical to a provision in the truly agreed to and finally passed CCS/HCS/SB 951 (2018), the truly agreed to and finally passed CCS/HCS/SCS/SB 718 (2018), and HCB 15 (2018).

LIMITATIONS ON PRESCRIBING OPIOIDS (Sections 195.010 and 195.080)

This act limits certain initial prescriptions of opioid controlled substances to no more than a 7-day supply for the treatment of acute pain. Prior to prescribing the opioid, a practitioner shall consult with the patient regarding the quantity of the opioid and the patient's option to fill the prescription in a lesser quantity, as well as inform the patient of the risks associated with the prescribed opioid. If, in the practitioner's medical judgment, more than a 7-day supply is required to treat the patient, the practitioner may issue a prescription for the quantity needed after noting in the patient's medical record the condition triggering the necessity for a greater quantity and that a nonopioid was not appropriate.

The provisions of this act shall not apply to prescriptions for a patient who is currently undergoing treatment for cancer, is receiving hospice care or palliative care, is a resident of a long-term care facility, or is receiving treatment for substance abuse or opioid dependence.

No pharmacy or pharmacist shall be liable or subject to disciplinary action for dispensing or refusing to dispense medication pursuant to an otherwise valid prescription that exceeds these prescribing limits.

These provisions are identical to provisions in the truly agreed to and finally passed CCS/HCS/SS/SCS/SB 826 (2018) and substantially similar to provisions in SCS/SB 825 (2018), HCB 15 (2018), and SCS/HCS/HB 1618 (2018).

DISPOSAL OF UNUSED CONTROLLED SUBSTANCES (Sections 195.070 and 195.265)

Under this act, a Drug Enforcement Agency-authorized collector, in accordance with federal regulations, may accept unused controlled substances from ultimate consumers, even if the authorized collector did not originally dispense the drug. This provision shall supersede and preempt any local drug disposal ordinance or regulation.

Additionally, the Department of Health and Senior Services shall develop an education and awareness program regarding drug disposal, including the development of a web-based resource and promotional activities.

These provisions are identical to provisions in the truly agreed to and finally passed CCS/HCS/SB 951 (2018), the truly agreed to and finally passed CCS/HCS/SCS/SB 718 (2018), the truly agreed to and finally passed CCS/HCS/SS/SCS/SB 826 (2018), substantially similar to provisions in HCB 15 (2018), and similar to provisions in SCS/HCS/HB 1618 (2018).

"OFFENDERS UNDER TREATMENT" PROGRAM (Section 217.364)

Under this act, if an offender requires treatment for opioid or other substance misuse or dependence, the Department of Corrections shall not prohibit the offender from participating in and receiving medication-assisted treatment under the care of a licensed physician and shall not be required to refrain from using medication-assisted treatment as a term or condition of his or her sentence.

This provision is identical to a provision in HCB 15 (2018).

SUBSTANCE ABUSE TREATMENT BY ASSISTANT PHYSICIANS (Sections 334.036 and 334.037)

This act adds treatment for substance abuse disorder or mental health services to the list of services an assistant physician in a collaborative practice arrangement may provide in medically under-served areas. Additionally, the requirement that the assistant physician practice with the collaborating physician a certain number of hours prior to prescribing controlled substances when the physician is not on-site shall not apply to assistant physicians providing opioid addiction treatment.

These provisions are identical to provisions in HCB 15 (2018) and similar to provisions in the truly agreed to and finally passed CCS/HCS/SB 951 (2018).

PATIENT SATISFACTION SCORES (Section 374.426)

Under this act, the Director of the Department of Insurance, Financial Institutions and Professional Registration shall not require patient scoring of pain control in defining data standards for quality of care and patient satisfaction. Beginning August 28, 2018, the Director shall discontinue the use of patient satisfaction scores and shall not make them available to the public to the extent allowable by federal law.

This provision is identical to a provision in the truly agreed to and finally passed CCS/HCS/SB 951 (2018), the truly agreed to and finally passed CCS/HCS/SCS/SB 718 (2018), and SCS/HCS/HB 2105 (2018).

"IMPROVED ACCESS TO TREATMENT FOR OPIOID ADDICTIONS ACT" (Section 630.875)

This act establishes the "Improved Access to Treatment for Opioid Addictions Program" to disseminate information and best practices regarding opioid addiction and to facilitate collaborations to better treat and prevent opioid addiction in Missouri, as specified in the act. The program shall facilitate collaborations between health care providers and provide resources to providers.

This act also specifies that assistant physicians who participate in the program shall complete the necessary requirements to prescribe buprenorphine within 30 days of joining. The program may develop curriculum and benchmark examinations on the subject of opioid addiction and treatment. A remote collaborating physician working with an on-site assistant physician shall be considered on-site for the purposes of the program. Additionally, an assistant physician collaborating with a physician who is waiver-certified for the use of buprenorphine may participate in the program in any area of the state and provide all services and functions of an assistant physician and other duties as specified in the act.

Under this act, when an overdose survivor arrives in an emergency department, the assistant physician serving as a recovery coach or another properly trained coach shall meet with the survivor and provide treatment options and support.

These provisions are substantially similar to provisions in the truly agreed to and finally passed CCS/HCS/SB 951 (2018), the truly agreed to and finally passed CCS/HCS/SCS/SB 718 (2018), and HCB 15 (2018).

This act has an emergency clause for certain provisions.

SARAH HASKINS


Go to Main Bill Page  |  Return to Summary List  |  Return to Senate Home Page